399 related articles for article (PubMed ID: 18668557)
1. Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes.
Khoury M; Escriou V; Courties G; Galy A; Yao R; Largeau C; Scherman D; Jorgensen C; Apparailly F
Arthritis Rheum; 2008 Aug; 58(8):2356-67. PubMed ID: 18668557
[TBL] [Abstract][Full Text] [Related]
2. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis.
Khoury M; Louis-Plence P; Escriou V; Noel D; Largeau C; Cantos C; Scherman D; Jorgensen C; Apparailly F
Arthritis Rheum; 2006 Jun; 54(6):1867-77. PubMed ID: 16729293
[TBL] [Abstract][Full Text] [Related]
3. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
4. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
5. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis.
Schiffelers RM; Xu J; Storm G; Woodle MC; Scaria PV
Arthritis Rheum; 2005 Apr; 52(4):1314-8. PubMed ID: 15818667
[TBL] [Abstract][Full Text] [Related]
6. Cytosolic phospholipase A2α gene silencing in the myeloid lineage alters development of Th1 responses and reduces disease severity in collagen-induced arthritis.
Courties G; Baron M; Presumey J; Escriou V; van Lent P; Scherman D; Cantagrel A; van den Berg WB; Jorgensen C; Apparailly F; Davignon JL
Arthritis Rheum; 2011 Mar; 63(3):681-90. PubMed ID: 21360497
[TBL] [Abstract][Full Text] [Related]
7. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
[TBL] [Abstract][Full Text] [Related]
8. Arthritic joint-targeting small interfering RNA-encapsulated liposome: implication for treatment strategy for rheumatoid arthritis.
Komano Y; Yagi N; Onoue I; Kaneko K; Miyasaka N; Nanki T
J Pharmacol Exp Ther; 2012 Jan; 340(1):109-13. PubMed ID: 21994423
[TBL] [Abstract][Full Text] [Related]
9. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid-induced leucine zipper is an endogenous antiinflammatory mediator in arthritis.
Beaulieu E; Ngo D; Santos L; Yang YH; Smith M; Jorgensen C; Escriou V; Scherman D; Courties G; Apparailly F; Morand EF
Arthritis Rheum; 2010 Sep; 62(9):2651-61. PubMed ID: 20496421
[TBL] [Abstract][Full Text] [Related]
11. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy.
Santel A; Aleku M; Keil O; Endruschat J; Esche V; Durieux B; Löffler K; Fechtner M; Röhl T; Fisch G; Dames S; Arnold W; Giese K; Klippel A; Kaufmann J
Gene Ther; 2006 Sep; 13(18):1360-70. PubMed ID: 16625242
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated virus type 5-mediated intraarticular administration of tumor necrosis factor small interfering RNA improves collagen-induced arthritis.
Khoury M; Courties G; Fabre S; Bouffi C; Seemayer CA; Vervoordeldonk MJ; Tak PP; Jorgensen C; Apparailly F
Arthritis Rheum; 2010 Mar; 62(3):765-70. PubMed ID: 20187132
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.
Koenders MI; Marijnissen RJ; Devesa I; Lubberts E; Joosten LA; Roth J; van Lent PL; van de Loo FA; van den Berg WB
Arthritis Rheum; 2011 Aug; 63(8):2329-39. PubMed ID: 21520013
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
15. Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophages.
Urasaki Y; Nori M; Iwata S; Sasaki T; Hosono O; Kawasaki H; Tanaka H; Dang NH; Ikeda E; Morimoto C
J Rheumatol; 2005 Sep; 32(9):1765-74. PubMed ID: 16142877
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the soluble form of the interleukin-1 receptor accessory protein as an inhibitor of interleukin-1 in collagen-induced arthritis.
Smeets RL; van de Loo FA; Joosten LA; Arntz OJ; Bennink MB; Loesberg WA; Dmitriev IP; Curiel DT; Martin MU; van den Berg WB
Arthritis Rheum; 2003 Oct; 48(10):2949-58. PubMed ID: 14558102
[TBL] [Abstract][Full Text] [Related]
17. Triptolide, a diterpenoid triepoxide, suppresses inflammation and cartilage destruction in collagen-induced arthritis mice.
Lin N; Liu C; Xiao C; Jia H; Imada K; Wu H; Ito A
Biochem Pharmacol; 2007 Jan; 73(1):136-46. PubMed ID: 17097618
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis.
Lee SW; Kim JH; Park MC; Park YB; Lee SK
Scand J Rheumatol; 2008; 37(4):260-8. PubMed ID: 18612926
[TBL] [Abstract][Full Text] [Related]
19. Immune modulation of collagen-induced arthritis by intranasal cytokine gene delivery: a model for the therapy of rheumatoid arthritis.
Woods AM; Thompson SJ; Wooley PH; Panayi G; Klavinskis LS
Arthritis Rheum; 2005 Dec; 52(12):3761-71. PubMed ID: 16329091
[TBL] [Abstract][Full Text] [Related]
20. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
